Sensex, Nifty Rebound After 6-Day Slump: Inflation, Value Buying Drive Gains

By By Rediff Money Desk, Mumbai
Feb 13, 2025 10:01
Indian stock markets rallied in early trade on Thursday, driven by lower-than-expected inflation and value-buying, following a six-day slump. Sensex rose 214 points, Nifty gained 69 points.
Illustration: Dominic Xavier/Rediff.com
Mumbai, Feb 13 (PTI) Equity benchmark indices Sensex and Nifty rebounded in early trade on Thursday following a better-than-expected decline in CPI inflation in January and value-buying at lower levels.

The 30-share BSE benchmark Sensex climbed 214.08 points to 76,385.16 in early trade. The NSE Nifty rallied 69.8 points to 23,115.05.

From the 30-share blue-chip pack, Kotak Mahindra Bank, Mahindra & Mahindra, Zomato, Bajaj Finserv, Bajaj Finance and Tata Steel were the biggest gainers.

Tech Mahindra, Titan, IndusInd Bank, Tata Consultancy Services, HCL Tech and Tata Motors were among the laggards.

Continuing the downward trend, retail inflation fell to a five-month low of 4.31 per cent in January, mainly due to a decline in the prices of vegetables, eggs, and pulses.

"A positive domestic trigger is the better-than-expected decline in CPI inflation in January to 4.31 per cent from 5.22 per cent in December 2024. The decline in inflation trajectory justifies the MPC's rate cut this month and creates a favourable condition for another 25 bps rate cut in April. This augurs well for the stock market in general and rate-sensitives in particular," V K Vijayakumar, Chief Investment Strategist, Geojit Financial Services, said.

In Asian markets, Seoul, Tokyo and Hong Kong were trading in the positive territory while Shanghai quoted lower.

US markets ended mostly lower on Wednesday.

Foreign Institutional Investors (FIIs) offloaded equities worth Rs 4,969.30 crore on Wednesday, according to exchange data.

"From the market perspective, the elephant in the room continues to be the sustained FII selling which is showing no signs of abating," Vijayakumar added.

Global oil benchmark Brent crude declined 0.98 per cent to USD 74.44 a barrel.

The BSE benchmark, which had tanked more than 900 points intra-day on Wednesday, ended at 76,171.08, down by 122.52 points or 0.16 per cent. The Nifty dipped 26.55 points or 0.12 per cent to 23,045.25, marking its sixth straight day of losses.

Since February 4 till February 12, the BSE bellwether gauge had slumped 2,412.73 points or 3.07 per cent, while the Nifty tanked 694 points or 2.92 per cent.
Source: PTI
Read More On:
indian stock marketsensexniftyinflationcpi inflationvalue buyingmarket reboundstock marketgeojit financial servicesfii sellingbrent crude
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

FTCCI Excellence Awards 2025: Entries Open in...

The Federation of Telangana Chambers of Commerce and Industry (FTCCI) has announced its...

India Poised to Become Global Toy Export Hub...

US-China tariff war creates opportunity for India to emerge as a leading toy exporter....

Vedanta's Rs 50,000 cr Assam Investment: Plan...

Assam CM Himanta Biswa Sarma met with Vedanta Group to discuss a detailed plan for...

Essar Energy Transition Appoints New CIO for...

Essar Energy Transition's EET Fuels has appointed Prashant Janaswamy as its Chief...

IHCL Expands Portfolio to 380 Hotels in FY25

Indian Hotels Company (IHCL) has expanded its footprint to 380 hotels, adding 100 new...

Delhi Airport: IndiGo, Akasa Shift Flights to...

IndiGo and Akasa Air will shift their domestic flights to Delhi airport's Terminal 1...

Capitalmind Mutual Fund Gets Sebi Approval

Capitalmind Financial Services receives final approval from SEBI to launch its mutual...

Transrail Lighting Wins Rs 1,085 Cr T''D Orders

Transrail Lighting has secured new orders worth Rs 1,085 crore in the domestic T''D...

Moom Health Raises $3.5 Million for Women's...

Moom Health, a women's health supplement brand focused on Asian women, secures $3.5...

Mankind Pharma to Integrate Bharat Serums &...

Mankind Pharma announces plans to integrate Bharat Serums & Vaccines (BSV). A committee...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com